Acute effect of sodium nitroprusside on microvascular dysfunction in patients who underwent percutaneous coronary

Kotaro Morimoto1, Shigenori Ito, Kosuke Nakasuka

  • 1Division of Cardiology, Asahi Rosai Hospital, Japan.

International Heart Journal
|December 22, 2012
PubMed

Insights

Nitroprusside (NTP) effectively improved coronary microvascular dysfunction after ST-segment elevation myocardial infarction (STEMI) percutaneous coronary intervention (PCI). This intervention normalized microvascular resistance in 50% of patients, suggesting a potential prognostic benefit.

Area of Science:

  • Cardiology
  • Interventional Cardiology
  • Cardiovascular Research

Background:

  • Microvascular dysfunction persists even with advanced treatments for ST-segment elevation acute myocardial infarction (STEMI).
  • Improving microvascular function is crucial for enhancing prognosis and left ventricular function post-STEMI.

Purpose of the Study:

  • To evaluate the acute effects of intracoronary nitroprusside (NTP) on coronary microvascular injury following primary percutaneous coronary intervention (PCI) in STEMI patients.
  • To assess the impact of NTP on the index of microcirculatory resistance (IMR) in the acute phase post-PCI.

Main Methods:

  • The study included 18 patients with STEMI undergoing primary PCI.
  • Intracoronary nitroprusside (NTP) was administered to assess its effect on coronary microcirculation.
  • Index of Microcirculatory Resistance (IMR) was measured before and after NTP administration.

Main Results:

  • Intracoronary NTP significantly improved IMR from a baseline of 76 ± 42 to 45 ± 37 (P = 0.0006).
  • Normal IMR (< 30) was achieved in 50% of patients (9 out of 18).
  • Patients with higher baseline TIMI flow grade and lower baseline IMR were more likely to achieve normal IMR after NTP.

Conclusions:

  • Nitroprusside administration acutely improves microcirculatory dysfunction in STEMI patients post-PCI, even with final TIMI 3 flow.
  • These findings highlight NTP's potential role in managing microvascular injury during STEMI treatment.
  • Further research is warranted to confirm the prognostic implications of NTP-induced microvascular improvement.

Related Concept Videos

Antihypertensive Drugs: Vasodilators01:23

Antihypertensive Drugs: Vasodilators

Vasodilators, primarily affecting the smooth muscles within arterial and venous walls, are commonly used for hypertension treatment. Medications such as minoxidil and hydralazine primarily target arteries and arterioles, while sodium nitroprusside acts on arterioles and venules. Minoxidil, functioning as a prodrug, is metabolized by hepatic sulfotransferase into its active form, minoxidil sulfate, after oral administration. This metabolite binds to the sulfonylurea receptor (SUR) component of...
Antianginal Drugs: Nitrates and &#946;-Blockers01:16

Antianginal Drugs: Nitrates and β-Blockers

In cardiovascular health, antianginal drugs combat angina pectoris — a condition marked by chest pain owing to diminished blood flow to the heart.
Organic nitrates,  such as nitroglycerin, play a pivotal role. Once metabolized, they liberate nitric oxide, a molecular marvel. Nitric oxide triggers guanylyl cyclase and augments cGMP production. This biochemical cascade orchestrates the relaxation of vascular smooth muscles, ushering in vasodilation and enhancing coronary blood flow. Administered...
Acute Coronary Syndrome IV: Interprofessional Care01:28

Acute Coronary Syndrome IV: Interprofessional Care

IntroductionThe management of Acute Coronary Syndrome (ACS) aims to minimize myocardial damage, preserve myocardial function, and prevent complications.Initial ManagementInpatient management involves continuous cardiac monitoring, preferably in an ICU, focusing on blood pressure, serum sodium, potassium, and creatinine levels, and urine output. Ongoing pharmacologic management is crucial for stabilizing the patient.Supplemental Oxygen: Administer supplemental oxygen if oxygen saturation is...
Acute Coronary Syndrome I: Introduction01:30

Acute Coronary Syndrome I: Introduction

Acute Coronary Syndrome (ACS) encompasses a spectrum of heart conditions caused by sudden obstruction of coronary arteries, typically resulting from the rupture of an atherosclerotic plaque and subsequent thrombus (blood clot) formation. This obstruction can lead to partial or complete blockage of blood flow, causing varying degrees of myocardial ischemia or infarction.ACS includes the following clinical entities:Unstable Angina (UA)Non-ST-Elevation Myocardial Infarction (NSTEMI)ST-Elevation...
Acute Coronary Syndrome V: Nursing Management01:26

Acute Coronary Syndrome V: Nursing Management

Nursing Assessment:Nursing management of acute coronary syndrome (ACS) involves taking the patient's history, focusing on primary complaints such as chest pain, dyspnea, and excessive sweating (diaphoresis), as well as other symptoms like back or jaw pain, nausea, vomiting, palpitations, dizziness, and fatigue. The nurse also reviews the patient's history of cardiac events, risk factors such as hypertension, diabetes, smoking, family history, and current medications.In the objective assessment,...
Acute Coronary Syndrome III: Diagnostic Studies01:30

Acute Coronary Syndrome III: Diagnostic Studies

Diagnosing acute coronary syndrome or ACS begins with a thorough patient history. Notable symptoms include central, crushing chest pain radiating to the left arm, neck, jaw, or back, along with shortness of breath, sweating (diaphoresis), nausea, vomiting, dizziness, and palpitations.It is crucial to note any history of cardiac illnesses and assess risk factors, including age, gender, smoking, hypertension, diabetes, hyperlipidemia, and a sedentary lifestyle.During physical examination, vital...